Iradimed Corp. (IRMD) Tops Q3 EPS by 7c

Iradimed Corp. (NASDAQ: IRMD) reported Q3 EPS of $0.43, $0.07 better than the analyst estimate of $0.36. Revenue for the quarter came in at $16.5 million versus the consensus estimate of $16.18 million.

For earnings history and earnings-related data on Iradimed Corp. (IRMD) click here.

You May Also Be Interested In

• onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
• Johnson & Johnson (JNJ) PT Raised to $270 at Guggenheim
• Benchmark Reiterates Buy Rating on IMAX Corporation (IMAX), Highlights 'The Odyssey' Potential